(Total Views: 516)
Posted On: 10/05/2017 5:27:00 PM
Post# of 98250
$RVXCF up over 20% this week so far....
Not as good as what a sub penny stock does of course...Phase III clinical trial of Diabetes patients on going for 2 years now, planned trials for Fabrys disease and Chronic Kidney Disease as well....Apabetalone could be a blockbuster.
Not as good as what a sub penny stock does of course...Phase III clinical trial of Diabetes patients on going for 2 years now, planned trials for Fabrys disease and Chronic Kidney Disease as well....Apabetalone could be a blockbuster.
(0)
(0)
Check out my blog if you like: Avoid The Bag
Scroll down for more posts ▼
